Dr. Rentschler Holding

Dr. Rentschler Holding is the family-owned parent company of the Rentschler Group, primarily known for its operating subsidiary Rentschler Biopharma SE. As a leading global Contract Development and Manufacturing Organization (CDMO), the company specializes in the process development and GMP manufacturing of complex biopharmaceuticals, including monoclonal antibodies and recombinant proteins. The group provides end-to-end solutions from clinical phase supply to large-scale commercial production. With facilities in Germany, the United States, and a dedicated cell and gene therapy center in the United Kingdom, the company serves a diverse global client base ranging from startups to large pharmaceutical firms. The holding structure ensures long-term stability and a focus on high-quality bioprocessing innovation.